中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 9
Sep.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(9): 2177-2179

Treatment of refractory hepatic hydrothorax by intrapleural injection of lauromacrogol: A case report

DOI: 10.3969/j.issn.1001-5256.2021.09.033

  • Department of Gastroenterology, Chengde Central Hospital, Chengde, Hebei 067000, China

Research funding:

Hebei Medical Science Research Project 2019 (20191297)

  • Received Date: 2021-01-22
  • Accepted Date: 2021-02-15
  • Published Date: 2021-09-20
    Abstract
    • FullText(HTML)
  • loading
    • References(31)
  • [1]
    AL-ZOUBI RK, ABU GHANIMEH M, GOHAR A, et al. Hepatic hydrothorax: Clinical review and update on consensus guidelines[J]. Hosp Pract (1995), 2016, 44(4): 213-223. DOI: 10.1080/21548331.2016.1227685.
    [2]
    SUÁREZ PM, GILART JL. Pleurodesis in the treatment of pneumothorax and pleural effusion[J]. Monaldi Arch Chest Dis, 2013, 79(2): 81-86. DOI: 10.4081/monaldi.2013.96.
    [3]
    ZAHID I, ROUTLEDGE T, BILLÈ A, et al. What is the best treatment for malignant pleural effusions?[J]. Interact Cardiovasc Thorac Surg, 2011, 12(5): 818-823. DOI: 10.1510/icvts.2010.254789.
    [4]
    RODRIGUEZ-PANADERO F, MONTES-WORBOYS A. Mechanisms of pleurodesis[J]. Respiration, 2012, 83(2): 91-98. DOI: 10.1159/000335419.
    [5]
    AGARWAL R, KHAN A, AGGARWAL AN, et al. Efficacy & safety of iodopovidone pleurodesis: A systematic review & meta-analysis[J]. Indian J Med Res, 2012, 135: 297-304.
    [6]
    CHAI Y, ZHOU Z, SONG J, et al. Safety of intralesional injection of lauromacrogol combined with triamcinolone for infantile hemangiomas[J]. J Dermatol, 2019, 46(9): 770-776. DOI: 10.1111/1346-8138.14992.
    [7]
    SCHIBLER F, BORRADORI L, RAMELET AA. Subcutaneous injection of large volumes of polidocanol[J]. Dermatol Surg, 2019, 45(3): 476-477. DOI: 10.1097/DSS.0000000000001544.
    [8]
    TU CY, CHEN CH. Spontaneous bacterial empyema[J]. Curr Opin Pulm Med, 2012, 18(4): 355-358. DOI: 10.1097/MCP.0b013e328352b50f.
    [9]
    NORVELL JP, SPIVEY JR. Hepatic hydrothorax[J]. Clin Liver Dis, 2014, 18(2): 439-449. DOI: 10.1016/j.cld.2014.01.005.
    [10]
    WINTER H, DRÄGER E, STERRY W. Sclerotherapy for treatment of hemangiomas[J]. Dermatol Surg, 2000, 26(2): 105-108. DOI: 10.1046/j.1524-4725.2000.98012.x.
    [11]
    GROVER C, KHURANA A, BHATTACHARYA SN. Sclerotherapy for the treatment of infantile hemangiomas[J]. J Cutan Aesthet Surg, 2012, 5(3): 201-203. DOI: 10.4103/0974-2077.101383.
    [12]
    TREMBLAY A, STATHER DR, KELLY MM. Effect of repeated administration of low-dose silver nitrate for pleurodesis in a rabbit model[J]. Respirology, 2011, 16(7): 1070-1075. DOI: 10.1111/j.1440-1843.2011.02007.x.
    [13]
    CHEN Y, LI C, XU L, et al. Novel treatment for chylothorax after esophagectomy with 50% glucose pleurodesis[J]. Ann Vasc Surg, 2010, 24(5): 694. e9-e13. DOI: 10.1016/j.avsg.2009.10.021.
    [14]
    FUJINO K, MOTOOKA Y, KOGA T, et al. Novel approach to pleurodesis with 50% glucose for air leakage after lung resection or pneumothorax[J]. Surg Today, 2016, 46(5): 599-602. DOI: 10.1007/s00595-015-1223-2.
    [15]
    ROUSSOS A, PHILIPPOU N, MANTZARIS GJ, et al. Hepatic hydrothorax: Pathophysiology diagnosis and management[J]. J Gastroenterol Hepatol, 2007, 22(9): 1388-1393. DOI: 10.1111/j.1440-1746.2007.05069.x.
    [16]
    BADILLO R, ROCKEY DC. Hepatic hydrothorax: Clinical features, management, and outcomes in 77 patients and review of the literature[J]. Medicine (Baltimore), 2014, 93(3): 135-142. DOI: 10.1097/MD.0000000000000025.
    [17]
    KIAFAR C, GILANI N. Hepatic hydrothorax: Current concepts of pathophysiology and treatment options[J]. Ann Hepatol, 2008, 7(4): 313-320. http://www.annalsofhepatology.com/PDF/vol7n4/Hp084-02.pdf
    [18]
    LIEBERMAN FL, HIDEMURA R, PETERS RL, et al. Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites[J]. Ann Intern Med, 1966, 64(2): 341-351. DOI: 10.7326/0003-4819-64-2-341.
    [19]
    YALCIN NG, CHOONG CK, EIZENBERG N. Anatomy and pathophysiology of the pleura and pleural space[J]. Thorac Surg Clin, 2013, 23(1): 1-10. DOI: 10.1016/j.thorsurg.2012.10.008.
    [20]
    LV Y, HAN G, FAN D. Hepatic hydrothorax[J]. Ann Hepatol, 2018, 17(1): 33-46. DOI: 10.5604/01.3001.0010.7533.
    [21]
    VILLENA GARRIDO V, CASES VIEDMA E, FERNÁNDEZ VILLAR A, et al. Recommendations of diagnosis and treatment of pleural effusion. Update[J]. Arch Bronconeumol, 2014, 50(6): 235-249. DOI: 10.1016/j.arbres.2014.01.016.
    [22]
    BORCHARDT J, SMIRNOV A, METCHNIK L, et al. Treating hepatic hydrothorax[J]. BMJ, 2003, 326(7392): 751-752. DOI: 10.1136/bmj.326.7392.751.
    [23]
    SINGH A, BAJWA A, SHUJAAT A. Evidence-based review of the management of hepatic hydrothorax[J]. Respiration, 2013, 86(2): 155-173. DOI: 10.1159/000346996.
    [24]
    LEE WJ, KIM HJ, PARK JH, et al. Chemical pleurodesis for the management of refractory hepatic hydrothorax in patients with decompensated liver cirrhosis[J]. Korean J Hepatol, 2011, 17(4): 292-298. DOI: 10.3350/kjhep.2011.17.4.292.
    [25]
    FELLER-KOPMAN D, LIGHT R. Pleural disease[J]. N Engl J Med, 2018, 378(8): 740-751. DOI: 10.1056/NEJMra1403503.
    [26]
    WEST JB. Snorkel breathing in the elephant explains the unique anatomy of its pleura[J]. Respir Physiol, 2001, 126(1): 1-8. DOI: 10.1016/s0034-5687(01)00203-1.
    [27]
    WEST JB. Why doesn't the elephant have a pleural space?[J]. News Physiol Sci, 2002, 17: 47-50. DOI: 10.1152/nips.01374.2001.
    [28]
    MIERZEJEWSKI M, KORCZYNSKI P, KRENKE R, et al. Chemical pleurodesis - a review of mechanisms involved in pleural space obliteration[J]. Respir Res, 2019, 20(1): 247. DOI: 10.1186/s12931-019-1204-x.
    [29]
    STRUNK H, MARINOVA M. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic basics, actual indications and results with review of the literature[J]. Rofo, 2018, 190(8): 701-711. DOI: 10.1055/a-0628-7347.
    [30]
    DHANASEKARAN R, WEST JK, GONZALES PC, et al. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis[J]. Am J Gastroenterol, 2010, 105(3): 635-641. DOI: 10.1038/ajg.2009.634.
    [31]
    VIZZUTTI F, SCHEPIS F, ARENA U, et al. Transjugular intrahepatic portosystemic shunt (TIPS): Current indications and strategies to improve the outcomes[J]. Intern Emerg Med, 2020, 15(1): 37-48. DOI: 10.1007/s11739-019-02252-8.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(5)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (432) PDF downloads(32) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return